1060 related articles for article (PubMed ID: 16987544)
21. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
23. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
24. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
[TBL] [Abstract][Full Text] [Related]
25. Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.
Shelley WE; Starreveld AA; Carmichael JA; O'Connell G; Roy M; Swenerton K
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):327-32. PubMed ID: 3347416
[TBL] [Abstract][Full Text] [Related]
26. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
Pickel H; Lahousen M; Petru E; Stettner H; Hackl A; Kapp K; Winter R
Gynecol Oncol; 1999 Feb; 72(2):215-9. PubMed ID: 10021304
[TBL] [Abstract][Full Text] [Related]
27. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis in ovarian cancer as a function of the results of the second-look laparatomy].
Varette C; de Gramont A; Louvet C; Gonzalez-Canali G; Krulik M; Drolet Y; Pigné A; Marpeau L; Barrat J; Gallot D
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):222-7. PubMed ID: 2723353
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.
Barakat RR; Almadrones L; Venkatraman ES; Aghajanian C; Brown C; Shapiro F; Curtin JP; Spriggs D
Gynecol Oncol; 1998 Apr; 69(1):17-22. PubMed ID: 9570993
[TBL] [Abstract][Full Text] [Related]
30. Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary.
Nagai Y; Inamine M; Hirakawa M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
Gynecol Oncol; 2007 Dec; 107(3):469-73. PubMed ID: 17765295
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
32. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL
Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
[TBL] [Abstract][Full Text] [Related]
33. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
34. [Value of tumor-reductive secondary operation (interventional laparotomy) in ovarian cancer].
Meier W; Römisch M; Hepp H
Geburtshilfe Frauenheilkd; 1993 Dec; 53(12):860-5. PubMed ID: 8119569
[TBL] [Abstract][Full Text] [Related]
35. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
Capretti PG; Zeppieri MC; Simonetti A; Rosato S; Lovotti D; Battaini A; Capretti G; Agnes Pradelli B
Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
[TBL] [Abstract][Full Text] [Related]
36. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer.
Dinniwell R; Lock M; Pintilie M; Fyles A; Laframboise S; Depetrillo D; Levin W; Manchul L; Murphy J; Oza A; Rosen B; Sturgeon J; Milosevic M
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):104-10. PubMed ID: 15850909
[TBL] [Abstract][Full Text] [Related]
37. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
Landoni F; Pellegrino A; Cormio G; Milani R; Maggioni A; Mangioni C
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
[TBL] [Abstract][Full Text] [Related]
38. [The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].
Kaufmann M; Hanke J; Schmid H; Kühn W; Kubli F
Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):581-7. PubMed ID: 3770408
[TBL] [Abstract][Full Text] [Related]
39. The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment.
Onda T; Yoshikawa H; Yasugi T; Matsumoto K; Taketani Y
Jpn J Clin Oncol; 2010 Jan; 40(1):36-41. PubMed ID: 19820253
[TBL] [Abstract][Full Text] [Related]
40. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer.
Baiocchi G; Grosso G; di Re E; Fontanelli R; Raspagliesi F; di Re F
Gynecol Oncol; 1998 May; 69(2):151-6. PubMed ID: 9600823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]